NGM Biopharmaceuticals Probability of Future Stock Price Finishing Over 0.0
NGM Biopharmaceutica's future price is the expected price of NGM Biopharmaceutica instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of NGM Biopharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please specify NGM Biopharmaceutica's target price for which you would like NGM Biopharmaceutica odds to be computed.
NGM |
NGM Biopharmaceutica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NGM Biopharmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NGM Biopharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NGM Biopharmaceutica is not yet fully synchronised with the market data | |
| NGM Biopharmaceutica has some characteristics of a very speculative penny stock | |
| NGM Biopharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 4.42 M. Reported Net Loss for the year was (142.38 M) with loss before taxes, overhead, and interest of (125.73 M). | |
| NGM Biopharmaceuticals has about 297.81 M in cash with (132.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
NGM Biopharmaceutica Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NGM Stock often depends not only on the future outlook of the current and potential NGM Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NGM Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.5 M | |
| Cash And Short Term Investments | 147.2 M |
NGM Biopharmaceutica Technical Analysis
NGM Biopharmaceutica's future price can be derived by breaking down and analyzing its technical indicators over time. NGM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NGM Biopharmaceuticals. In general, you should focus on analyzing NGM Stock price patterns and their correlations with different microeconomic environments and drivers.
NGM Biopharmaceutica Predictive Forecast Models
NGM Biopharmaceutica's time-series forecasting models is one of many NGM Biopharmaceutica's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NGM Biopharmaceutica's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NGM Biopharmaceuticals
Checking the ongoing alerts about NGM Biopharmaceutica for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NGM Biopharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NGM Biopharmaceutica is not yet fully synchronised with the market data | |
| NGM Biopharmaceutica has some characteristics of a very speculative penny stock | |
| NGM Biopharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 4.42 M. Reported Net Loss for the year was (142.38 M) with loss before taxes, overhead, and interest of (125.73 M). | |
| NGM Biopharmaceuticals has about 297.81 M in cash with (132.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in NGM Stock
If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |